We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENERIC BIOLOGICS GUIDANCE ON SCIENTIFIC CHALLENGES OUT SOON
GENERIC BIOLOGICS GUIDANCE ON SCIENTIFIC CHALLENGES OUT SOON
March 9, 2004
The generic drug industry is moving closer to tapping into the nearly $10 billion worth of biological products going off patent in the next five years. The FDA is expected this spring to release a guidance on the scientific challenges in creating generic biologics.